Aquashine BR Soft Filler 1 x 2.0 ml

Aquashine BR Soft Filler combines 15 mg/ml non-cross-linked hyaluronic acid with 2 mg/ml tranexamic acid and a multi-component peptide–vitamin complex (including palmitoyl pentapeptide-4, vitamin C, glutathione and niacinamide). The HA acts as a hydrating carrier, creating a dermal reservoir that releases brightening actives over 5–7 days. Tranexamic acid inhibits tyrosinase and plasmin activity in melanocytes, reducing melanin synthesis, while palmitoyl peptides stimulate collagen and elastin synthesis. Vitamins C and glutathione provide antioxidant protection and further down-regulate melanogenesis. The pH is buffered to 7.0 ± 0.2 to ensure compatibility with dermal enzymes, and microbial filtration guarantees sterility; endotoxin levels remain under 0.25 EU/ml. Viscosity (\~1.2 cP) allows effortless passage through a 30 G needle without compromising even dispersion. sample

Aquashine BR Soft Filler is indicated for skin tone irregularities such as early melasma, post-inflammatory hyperpigmentation, and overall dullness, as well as fine lines associated with dehydration. Ideal candidates present Fitzpatrick II–IV skins with mild to moderate pigmentation spots, uneven tone, or first signs of photo-ageing. By combining tranexamic acid’s melanogenesis inhibition with peptide-driven dermal remodeling and HA’s hydrating lift, the product delivers both immediate glow and longer-term tone correction. Typical treatment involves micro-papular nappage (0.02 ml blebs, 1 cm grid) or 4-point cannula fanning across the cheeks, perioral and jawline areas. Sessions are spaced four weeks apart to build cumulative effect; maintenance every 6–9 months preserves brightness. s

Each sterile kit contains:
* 1 × 2 ml glass syringe pre-filled with Aquashine BR Soft Filler, graduated every 0.1 ml for precision
* 2 × 30 G ½″ needles (siliconised, Luer-Lock)
* 2 peel-off lot/expiry labels for patient and clinic records
* Multilingual Instructions-for-Use leaflet detailing storage (2–25 °C), injection techniques, after-care steps, and hyaluronidase protocol (5 IU per 0.1 ml)

All components are latex-free and ISO 10993-tested; unopened shelf life is 24 months. Discard any remaining product after single-patient use to maintain sterility.

Patients notice an immediate dewy radiance as HA hydrates the superficial dermis; within 7–10 days tranexamic acid and antioxidants begin to even tone and fade discoloration. Clinical photometric assessments show up to a 30 % reduction in melanin index at 4 weeks, with improvements persisting 6–9 months post-series. Fine-line smoothing and collagen boost from peptides become evident around week 4, with ultrasound-measured dermal thickness gains of \~0.2 mm. Maintenance boosters every 6 months sustain both hydration and brightness, while untreated pigmentation remains stable unless new UV exposure occurs.

Q1: Is the treatment painful?
A1: Discomfort is minimal—30 G needles and HA’s cushioning effect keep pain around 2/10; topical anesthetic may be used if needed.

Q2: How soon can I apply sunscreen or makeup?
A2: Broad-spectrum SPF and light mineral makeup are safe after 6 hours; avoid heavy creams for 24 hours to let actives absorb.

Q3: Can I combine this with laser or IPL?
A3: Yes—schedule Aquashine BR at least two weeks before or after energy-based treatments to optimize tone correction without overlapping inflammation.

Aquashine BR Soft Filler is produced by Caregen Co., Ltd. in ISO 13485-certified cleanrooms in South Korea. Caregen pioneered peptide-enhanced mesotherapy, holding over 150 patents. Each batch undergoes HPLC peptide profiling, tranexamic acid potency testing, endotoxin assay, and stability trials before release. Packaging now integrates 30 % recycled PET and FSC-certified paper as part of Caregen’s 2030 carbon-neutral roadmap. Distributed globally, Aquashine blends science-driven innovation with proven safety for targeted skin brightening and rejuvenation.